Table: Taiko Pharmaceutical - 9-MTH group results

Taiko Pharmaceutical

11/11/2022 06:30

Nov 11 (Reuters)- 
             Taiko Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2022        Sep 30, 2021      Dec 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             3.39                8.36              6.00      
  Operating       loss 2.75           loss 1.58         loss 2.80   
  Recurring       loss 2.90           loss 2.39         loss 3.00   
  Net                                                   loss 3.30   
  Net             loss 3.18           loss 1.95                     
  EPS          loss 72.97 yen      loss 44.79 yen    loss 75.67 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T